Anus Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2021-11-29
EMA Application withdrawn: Zynyz (retifanlimab) — Incyte Biosciences Distribution B.V.
The EMA has withdrawn the application for Zynyz (retifanlimab) by Incyte Biosciences Distribution B.V. for anus neoplasms and squamous cell …